If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksENRC.L Regulatory News (ENRC)

  • There is currently no data for ENRC

Form 8.5 (EPT/NON-RI)-Eurasian Natural Resources

26 Sep 2013 11:09

RNS Number : 9792O
Credit Suisse Securities (Eur) Ltd
26 September 2013
Β 

ο»Ώ

FORM 8.5 (EPT/NON-RI)

Β 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

Β 

Β 

1. KEY INFORMATION

Β 

(a) Name of exempt principal trader:

Credit Suisse Securities (Europe) Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Eurasian Natural Resources Corporation Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Eurasian Natural Resources Corporation Plc

(d) Date position held/dealing undertaken:

25-September-2013

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

Yes - Kazakhmys Plc

Β 

Β 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Β 

Class of relevant security:

Β 

Ordinary shares

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1,390,554

0.108

57,032

0.004

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

TOTAL:

1,390,554

0.108

57,032

0.004

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Β 

(b) Rights to subscribe for new securities (including directors' and other executive options)

Β 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchase/sale

Number of securities

Price per unit

Ordinary shares

S

512

217.20

Ordinary shares

S

8742

217.10

Ordinary shares

S

202

217.00

Ordinary shares

S

978

216.90

Ordinary shares

S

2107

216.70

Ordinary shares

S

535

216.40

Ordinary shares

S

3334

216.20

Ordinary shares

S

1223

216.10

Ordinary shares

S

707

216.00

Ordinary shares

S

1849

215.90

Ordinary shares

S

402

215.30

Ordinary shares

S

1672

215.20

Ordinary shares

B

21738

215.04

Ordinary shares

S

21738

215.04

Ordinary shares

B

6238

214.98

Ordinary shares

S

6238

214.98

Ordinary shares

S

2101

214.30

Ordinary shares

S

1053

214.20

Ordinary shares

S

2014

214.00

Ordinary shares

S

3749

213.90

Ordinary shares

S

1769

213.80

Ordinary shares

B

11730

213.74

Ordinary shares

S

1612

213.70

Ordinary shares

S

972

213.60

Ordinary shares

S

984

213.50

Total Purchases 39,706

Total Sales: 64,493

Β 

b) Derivatives transactions (other than options)

Β 

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Β 

Β 

Β 

(c) Options transactions in respect of existing securities

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercising

Β 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(c) Attachments

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Β 

Β 

Date of disclosure:

26-September-2013

Contact name:

Anthony Allen / Paul MacDonald

Telephone number:

0207 888 5416 / 8548

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
FEOGMGZLGVNGFZM
Date   Source Headline
22nd Apr 20139:30 amRNSForm 8.5 (EPT/RI) ENRC PLC
22nd Apr 20139:29 amRNSForm 8.5 (EPT/RI) ENRC PLC
19th Apr 20134:33 pmRNSResponse to Announcement
19th Apr 20131:50 pmRNSrecent press speculation
11th Apr 20133:30 pmRNSDirectorate Change
20th Mar 20137:00 amRNSFinal Results
27th Feb 201311:30 amRNSUpdate on Effective Tax Rate and Annual Impairment
6th Feb 20137:00 amRNSQ4 Production Report
28th Dec 20124:15 pmRNSCompletion of Acquisition
28th Dec 201211:00 amRNSResult of EGM
10th Dec 20124:21 pmRNSCirc re. Camrose acquisition
10th Dec 20127:00 amRNSAcquisition
23rd Nov 20127:00 amRNSBoard and Senior Management Changes
8th Nov 20127:00 amRNSQ3 Production Report and IMS
1st Oct 201211:06 amRNSPostponement of Proposed Copper Seminar
15th Aug 20127:00 amRNSHalf Yearly Report
10th Aug 20124:15 pmRNSChanges to Board Committees
1st Aug 20127:00 amRNSQ2 Production Report
31st Jul 20127:00 amRNSAcquisition of Frontier Licence
12th Jun 20123:15 pmRNSResult of AGM
29th May 20124:40 pmRNS2011 Sustainable Development Report
25th May 201212:36 pmRNSDirectorate Change
11th May 20125:39 pmRNSAnnual Information Update
10th May 20127:00 amRNSInterim Management Statement
8th May 20127:00 amRNSStatement re Press Speculation
4th May 20127:00 amRNSDirector/PDMR Shareholding
4th May 20127:00 amRNSDirector/PDMR Shareholding
4th May 20127:00 amRNSDirector/PDMR Shareholding
26th Apr 20125:12 pmRNSAnnual Financial Report
17th Apr 20127:00 amRNSCompletion of Shubarkol Acquisition
2nd Apr 20121:23 pmRNSResult of EGM
21st Mar 20126:04 pmRNSCirc re. reconvening of General Meeting
21st Mar 20127:00 amRNSFinal Results
21st Mar 20127:00 amRNSReconvening of General Meeting
2nd Mar 20121:30 pmRNSCompletion of Acquisition
2nd Mar 20121:30 pmRNSClosure of Previously Announced Transaction
28th Feb 201212:30 pmRNSLoan Facility
21st Feb 20122:45 pmRNSMMK Contract Update
3rd Feb 20122:33 pmRNSBoard Changes
1st Feb 20127:00 amRNSQ4 Production Report
5th Jan 201212:34 pmRNSFIRST QUANTUM REACHES AGREEMENT WITH ENRC
5th Jan 201212:28 pmRNSConference Call re Acquisition
5th Jan 201212:27 pmRNSAcquisition and Legal Settlement
14th Dec 20115:13 pmRNSDirector Declaration
5th Dec 20111:01 pmRNSENRC and MMK settled legal claims
10th Nov 20117:00 amRNSQ3 Production Report and IMS
7th Nov 20114:18 pmRNSResult of EGM
4th Nov 20113:30 pmRNSAdjournment of General Meeting
11th Oct 20115:30 pmRNSCirc re. Proposed Exercise of Option
11th Oct 201112:30 pmRNSSite Visits for Analysts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.